237 related articles for article (PubMed ID: 36430275)
1. PAC
Tasma Z; Siow A; Harris PWR; Brimble MA; O'Carroll SJ; Hay DL; Walker CS
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430275
[TBL] [Abstract][Full Text] [Related]
2. PACAP-38 but not VIP induces release of CGRP from trigeminal nucleus caudalis via a receptor distinct from the PAC1 receptor.
Jansen-Olesen I; Baun M; Amrutkar DV; Ramachandran R; Christophersen DV; Olesen J
Neuropeptides; 2014 Apr; 48(2):53-64. PubMed ID: 24508136
[TBL] [Abstract][Full Text] [Related]
3. Expression of Pituitary Adenylate Cyclase-activating Peptide, Calcitonin Gene-related Peptide and Headache Targets in the Trigeminal Ganglia of Rats and Humans.
Frederiksen SD; Warfvinge K; Ohlsson L; Edvinsson L
Neuroscience; 2018 Nov; 393():319-332. PubMed ID: 30336190
[TBL] [Abstract][Full Text] [Related]
4. Temporal alterations of pituitary adenylate cyclase activating polypeptide and its receptors in a rat model induced by recurrent chemical stimulations: Relevant to chronic migraine.
Wu H; Dong Z; Liu Y; Zhang Q; Zhang M; Hu G; Yu S; Han X
Mol Pain; 2023; 19():17448069231152129. PubMed ID: 36604785
[No Abstract] [Full Text] [Related]
5. Distribution of vasoactive intestinal peptide, pituitary adenylate cyclase-activating peptide, nitric oxide synthase, and their receptors in human and rat sphenopalatine ganglion.
Csati A; Tajti J; Kuris A; Tuka B; Edvinsson L; Warfvinge K
Neuroscience; 2012 Jan; 202():158-68. PubMed ID: 22108610
[TBL] [Abstract][Full Text] [Related]
6. Characterisation of agonist signalling profiles and agonist-dependent antagonism at PACAP-responsive receptors: Implications for drug discovery.
Tasma Z; Siow A; Harris PWR; Brimble MA; Hay DL; Walker CS
Br J Pharmacol; 2022 Feb; 179(3):435-453. PubMed ID: 34612509
[TBL] [Abstract][Full Text] [Related]
7. Dynamic changes in CGRP, PACAP, and PACAP receptors in the trigeminovascular system of a novel repetitive electrical stimulation rat model: Relevant to migraine.
Zhang Q; Han X; Wu H; Zhang M; Hu G; Dong Z; Yu S
Mol Pain; 2019; 15():1744806918820452. PubMed ID: 30799680
[TBL] [Abstract][Full Text] [Related]
8. Pituitary adenylate cyclase-activating polypeptide and PACAP receptor expression and function in the rat adrenal gland.
Mazzocchi G; Malendowicz LK; Neri G; Andreis PG; Ziolkowska A; Gottardo L; Nowak KW; Nussdorfer GG
Int J Mol Med; 2002 Mar; 9(3):233-43. PubMed ID: 11836629
[TBL] [Abstract][Full Text] [Related]
9. PACAP-38 Induces Transcriptomic Changes in Rat Trigeminal Ganglion Cells Related to Neuroinflammation and Altered Mitochondrial Function Presumably via PAC1/VPAC2 Receptor-Independent Mechanism.
Takács-Lovász K; Kun J; Aczél T; Urbán P; Gyenesei A; Bölcskei K; Szőke É; Helyes Z
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216232
[TBL] [Abstract][Full Text] [Related]
10. Chronic changes in pituitary adenylate cyclase-activating polypeptide and related receptors in response to repeated chemical dural stimulation in rats.
Han X; Ran Y; Su M; Liu Y; Tang W; Dong Z; Yu S
Mol Pain; 2017; 13():1744806917720361. PubMed ID: 28776455
[TBL] [Abstract][Full Text] [Related]
11. Localization of the neuropeptides pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal peptide, and their receptors in the basal brain blood vessels and trigeminal ganglion of the mouse CNS; an immunohistochemical study.
Lund AM; Hannibal J
Front Neuroanat; 2022; 16():991403. PubMed ID: 36387999
[TBL] [Abstract][Full Text] [Related]
12. Cellular distribution of PACAP-38 and PACAP receptors in the rat brain: Relation to migraine activated regions.
Warfvinge K; Edvinsson L
Cephalalgia; 2020 May; 40(6):527-542. PubMed ID: 31810401
[TBL] [Abstract][Full Text] [Related]
13. PACAP and its role in primary headaches.
Edvinsson L; Tajti J; Szalárdy L; Vécsei L
J Headache Pain; 2018 Mar; 19(1):21. PubMed ID: 29523978
[TBL] [Abstract][Full Text] [Related]
14. Expression of VPAC2 receptor and PAC1 receptor splice variants in the trigeminal ganglion of the adult rat.
Chaudhary P; Baumann TK
Brain Res Mol Brain Res; 2002 Aug; 104(2):137-42. PubMed ID: 12225867
[TBL] [Abstract][Full Text] [Related]
15. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.
Alexandre D; Anouar Y; Jegou S; Fournier A; Vaudry H
Endocrinology; 1999 Mar; 140(3):1285-93. PubMed ID: 10067855
[TBL] [Abstract][Full Text] [Related]
16. Stimulatory effect of pituitary adenylate cyclase-activating polypeptide 6-38, M65 and vasoactive intestinal polypeptide 6-28 on trigeminal sensory neurons.
Sághy É; Payrits M; Helyes Z; Reglődi D; Bánki E; Tóth G; Couvineau A; Szőke É
Neuroscience; 2015 Nov; 308():144-56. PubMed ID: 26321242
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of PACAP receptors in postnatal rat brain.
Shneider Y; Shtrauss Y; Yadid G; Pinhasov A
Neuropeptides; 2010 Dec; 44(6):509-14. PubMed ID: 20971507
[TBL] [Abstract][Full Text] [Related]
18. Immunocytochemical identification of VPAC1, VPAC2, and PAC1 receptors in normal and neoplastic human tissues with subtype-specific antibodies.
Schulz S; Röcken C; Mawrin C; Weise W; Höllt V; Schulz S
Clin Cancer Res; 2004 Dec; 10(24):8235-42. PubMed ID: 15623599
[TBL] [Abstract][Full Text] [Related]
19. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.
Akesson L; Ahrén B; Edgren G; Degerman E
Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088
[TBL] [Abstract][Full Text] [Related]
20. Differential expression pattern of pituitary adenylate cyclase-activating polypeptide (PACAP) alternative splicing variants and its receptors in the immune system of rainbow trout (Oncorhynchus mykiss).
Lugo JM; Tafalla C; Leceta J; Gomariz RP; Estrada MP
Fish Shellfish Immunol; 2011 Feb; 30(2):734-8. PubMed ID: 21168508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
